Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Dr. Reddy's Laboratories Ltd ADR
(NY:
RDY
)
83.47
+1.20 (+1.46%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dr. Reddy's Laboratories Ltd ADR
< Previous
1
2
3
4
5
6
Next >
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
September 10, 2021
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Via
Benzinga
Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma
September 07, 2021
Citius Pharmaceuticals Inc has agreed to acquire anti-cancer agent E7777 from Dr. Reddy's Laboratories Ltd (NYSE: RDY). E7777 is an engineered IL-2-...
Via
Benzinga
Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)
September 04, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Mu - The Newest Worry
September 03, 2021
Today London and New York fell on the huge drop in new employment levels in August.
Via
Talk Markets
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market
September 02, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Dr. Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market
August 31, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
Delta Outbreak
August 04, 2021
The US market was droopy because of poor private sector jobless numbers.
Via
Talk Markets
BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range
August 04, 2021
BioDelivery Sciences International Inc (NASDAQ: BDSI) has reported Q2 sales of $41.4 million, + 13.3% Y/Y, missing the consensus of $42.4 million. Sales growth...
Via
Benzinga
Dr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL
August 04, 2021
From
Dr. Reddy’s Laboratories Limited
Via
Business Wire
Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market
August 03, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
DrReddy's Laboratories Ltd (RDY) Q1 2022 Earnings Call Transcript
July 29, 2021
RDY earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Full News Day
July 28, 2021
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier.
Via
Talk Markets
Topics
Energy
Exposures
Fossil Fuels
Banned Merger
July 27, 2021
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood.
Via
Talk Markets
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 27, 2021
Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 131.41% to $7.22 during Tuesday's pre-market session. The company's market cap stands at $51.2...
Via
Benzinga
Joblessness Surprise
July 22, 2021
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices.
Via
Talk Markets
Delta Defeats Bulls
July 19, 2021
Stocks tended to crash without rhyme or reason.
Via
Talk Markets
Fireworks Display
July 05, 2021
The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked.
Via
Talk Markets
Stocks That Hit 52-Week Highs On Friday
July 02, 2021
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs. Interesting Facts: The largest company by market cap to set a new 52-week high was Microsoft (NASDAQ:...
Via
Benzinga
New Month And Half Year
July 01, 2021
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up.
Via
Talk Markets
Dr. Reddy's Laboratories Announces Filing of Annual Report on Form 20-F
June 30, 2021
From
Dr. Reddy’s Laboratories Limited
Via
Business Wire
Stocks That Hit 52-Week Highs On Thursday
July 01, 2021
This morning 158 companies set new 52-week highs. Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a new 52-week high. The...
Via
Benzinga
Moderna Stock Surges To Record High As Covid Battle Rages In India
June 29, 2021
Moderna stock surged to a record high Tuesday after its Covid vaccine protected against a handful of variants in an early-phase study.
Via
Investor's Business Daily
Exposures
COVID-19
Saint Warren
June 28, 2021
Today the WTI oil price rose further up over 1%.
Via
Talk Markets
Crazy Thursday
June 24, 2021
Today the US stock market went ballistic probably because of a higher joblessness level than expected.
Via
Talk Markets
Why Amarin Fell Again Today
June 22, 2021
Another Vascepa generic is launched in the U.S.
Via
The Motley Fool
Topics
Intellectual Property
Exposures
Intellectual Property
Reconsidered Boom
June 22, 2021
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded.
Via
Talk Markets
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market
June 22, 2021
From
Dr. Reddy’s Laboratories Ltd.
Via
Business Wire
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
June 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.